机译:siRNA介导的IAP基因(Livin,XIAP和Survivin)联合敲低对人膀胱癌T24细胞的治疗潜力
Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China;
rnDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China;
Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;
rnDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China;
livin; XIAP; survivin; bladder cancer; multi-targeted therapy;
机译:siRNA介导的lAP基因(Livin,XIAP和Survivin)联合敲低对人膀胱癌T24细胞的治疗潜力
机译:siRNA介导的膀胱癌细胞中抗凋亡BCL2,Bcl-xL,XIAP和survivin的敲低
机译:一种新型的小分子IAP拮抗剂AZD5582,通过靶向CIAP1和XIAP在人胰腺癌中诱导诱导细胞凋亡的MCL-1下调
机译:结直肠癌的两个新治疗靶点的基本原理:HAUSP和XIAP。
机译:siRNA介导的膀胱癌细胞中抗凋亡BCL2Bcl-xLXIAP和survivin的敲低
机译:SiRNA介导的IAP基因组合敲低对人膀胱癌T24细胞的IAP基因(Livin,XIAP和Survivin)的疗效潜力
机译:XIap在炎症性乳腺癌治疗耐药中的作用